Patents/Assignees

Boehringer Ingelheim International GmbH

142 patents in portfolio

US11883580utility2024
Nebulizer and Cartridge
0 cites
US11884652utility2024
Tetrazole Derivatives as TRPA1 Inhibitors
0 cites
US11884681utility2024
3h,4h,5h,6h,7h-pyrimido[4,5-b][1,4]oxazine-4,6-dione Derivatives as TRPA1 Inhibitors
0 cites
US11878981utility2024
Substituted 1,2,4-oxadiazoles as TRPA1 Inhibitors
0 cites
US11866501utility2024
Anti-trkb Antibodies
0 cites
US11858921utility2024
Uracil Derivatives as TRPA1 Inhibitors
0 cites
US11851418utility2023
Heteroaromatic Carboxamide Derivatives as Plasma Kallikrein Inhibitors
0 cites
US11851495utility2023
TRAILR2 CDH17 Binding Molecules for the Treatment of Cancer
0 cites
US11833166utility2023
Pharmaceutical Composition, Methods for Treating and Uses Thereof
0 cites
US11813266utility2023
Combination of Active Agents for the Treatment of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
0 cites
US11813275utility2023
Pharmaceutical Composition, Methods for Treating and Uses Thereof
0 cites
US11813312utility2023
Glucagon Analogues as Long-acting Glp-1/glucagon Receptor Agonists in the Treatment of Fatty Liver Disease and Steatohepatitis
0 cites
US11814380utility2023
Benzylamino Substituted Pyridopyrimidinones and Derivatives as SOS1 Inhibitors
0 cites
US11795147utility2023
Modulators of Complex I
0 cites
US11795219utility2023
Antibody Molecules for Cancer Treatment
0 cites
US11771848utility2023
Nebulizer and Reservoir
0 cites
US11766443utility2023
Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists
0 cites
US11760745utility2023
Heteroaromatic Carboxamide Derivatives as Plasma Kallikrein Inhibitors
0 cites
US11730812utility2023
Anti-il-36r Antibody Formulations
0 cites
US11732045utility2023
Multi-specific Binding Proteins for Cancer Treatment
0 cites

← PreviousPage 6 of 8Next →